ANTIDIABETIC ACTIVITY OF INDIAN MAHAGONI PLANT EXTRACT BY TRANSDERMAL THERAPY

Stephan R; Jeyabharathi S; Jeenathunisa N; Deena Priscilla H

doi:10.22159/ajpcr.2018.v11i4.23234

Authors

Stephan R Department of Botany, Government Arts College, Ariyalur - 621 713, Tamil Nadu, India. http://orcid.org/0000-0002-8994-3923
Jeyabharathi S Department of Botany, Government Arts College, Ariyalur - 621 713, Tamil Nadu, India.
Jeenathunisa N Department of Microbiology, Cauvery College for Women, Tiruchirappalli - 620 018, Tamil Nadu, India.
Deena Priscilla H Department of Microbiology, Cauvery College for Women, Tiruchirappalli - 620 018, Tamil Nadu, India.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i4.23234

Keywords:

Modern drugs, Transdermal therapy, Swietenia mahagoni, Diabetes mellitus, Streptozotocin, Insulin

Abstract

Â Objective: Most of the medicinal products are originated from nature and considered as a rich source for producing herbal drugs with modern approach. Swietenia mahagoni is one of the most important plants of the Meliaceae family. This plant has been reported to treat diabetes without adverse effects by local communities since long time. The present work is aimed on the transdermal therapy using seed extract of S. mahagoni in streptozotocin (STZ)-induced diabetes mellitus in male Wistar rats.

Methods: The induction of diabetic state by STZ injection and the biochemical analyses such as blood glucose, serum protein, albumin, cholesterol, urea, and alkaline phosphatase was monitored before and after treatment.

Results: This present study showed there was a significant (p<0.01) increase in the blood glucose level in diabetics, as well as, diabetics treated with insulin transdermally. However, there was significant reduction (p<0.05) in the hyperglycemic state in diabetic animal, which is transdermally treated with seed extract.

Conclusion: Thus, the results showed that this type of drug delivery could provide a pain-free physiological insulin balance among the patients.

Downloads

Download data is not yet available.

Author Biography

Stephan R, Department of Botany, Government Arts College, Ariyalur - 621 713, Tamil Nadu, India.

Department of Microbiology,

Assistant Professor

References

Rastogi RP, Mehotra BN. Compendium of Indian Medicinal Plants. Vol. 1. New Delhi: CSIR Publication; 1990. p. 1960-9.

Arumugasamy K, Latha KV, Kumar NH. Studies on some pharmacognostic profiles of Swietenia macrophylla. King. Anc Sci Life 2004;24:97-102.

Madhumitha S, Vinothkumar D, Babu NG. Phytochemical analysis and antibacterial activity of Swietenia mahagoni: A highly medicinal plant in India. Asian J Pharm Sci Clin Res 2016;9:62-4.

Rao MY, Vani G, Chary BR. Design and evaluation of muco adhesive drug delivery systems. Indian Drugs 1998;35:558-65.

Rao PR, Diwan PV. Formulation and in vitro evolution of polymeric films of diltiazen hydrochloride and indomethacin for transdermal administration. Drug Dev Indian Pharm 1998;24: 327-36.

Andrew J Thompson, Alison C Jackson, Rachael C Symonds, Barry J Mulholland, A Ruth Dadswell, Patrick S Blake, Alan Burbidge, Ian B Taylor. Ectopic expression of a tomato 9-cis-epoxycarotenoid dioxygenase gene causes over-production of abscisic acid. Plant J 2000;23:363-74.

Hajra S, Mehta A, Pandey P. Phenolic compounds and antioxidant activity of Swietenia mahagoni seeds. Int J Pharm Pharm Sci 2011;3:431-4.

Thacharodi D, Rao KP. Rate â€“ Controlling bio molecular membranes as transdermal delivery systems for nifedipine: Development and in vitro evaluations. Biomaterials 1996;17;1307-11.

Kadota S, Marpaung L, Kikuchi T, Ekimoto H. Constituents of the seed of Swietenia mahagoni JACQ. I. Isolations, structures and 1H and 13C nuclear magnetic resonance signal assignment of new tetranortriterpenoids related to Swietenine and Swietenolide. Chem Pharm Bull 1990;38:639-51.

Falah S, Suzuki T, Katayama T. Chemical Constituents from Swietenia macrophylla bark and their antioxidant activity. Pak J Biol Sci 2008;16:2007-12.

Bacsal K, Chavez L, Diaz I, Espina S, Javillo J, Manzanilla H, et al. The effect of Swietenia mahogani (Mahogany) seed extract on indomethacin-induced gastric ulcers in female Sprague-Dawley rats. Acta Med Philipp 1997;33:127-39.

Krishna R, Pandit JK. Carboxymethylcellulose-sodium based transdermal drug delivery system for propranolol. J Pharm Pharmacol 1996;48:367-70.

Kulisic T, Radonic A, Katalinic V, Milos M. Use of different methods for antioxidative activity of oregano essential oil. Food Chem 2004;85:633-40.

Majid MA, Rahman IM, Shipar MA, Helal UM, Chowdhury R. Physico-chemical characterization. Antimicrobial activity and toxicity analysis of Swietenia mahagoni oil. Int J Agric Biol 2004;6:350-4.

Potts RO, Cleary GW. Transdermal drug delivery: Useful paradigms. J Drug Target 1995;3:247-51.

Kalia YN, Merino V, Guy RH. Transdermal drug delivery. Clin Aspects 1990;1:361-8.

Adedapo AA, Ofuegbe SO, Adeyemi AA. The anti-diabetic activities of the methanol leaf extract of Phyllanthus amarus in some laboratory animals. Asian J Med Sci 2013;4:23-34.

Naik A, Kalia YN, Guy RH. Transdermal drug delivery: Overcoming the skinâ€™s barrier function. Pharm Sci Technolo Today 2000;3:318-26.

Glenn GM, Dietrich G, Werner G. Transcutaneous Immunization in Vaccine Delivery Strategies. Norfolk UK: Horizon Scientific Press; 2002. p. 53-81.

Hampenstall PD, Campbell JP, Bajurnow T, Reed PC, Harrison LC. Cardiovascular, bio chemical and hormonal response to intravenous sedation with local analgeica versus general anesthesia in patients undergoing oral surgery. J Oral Maxillofaec Surg 1986;44:441-6.

Naveen YP, Urooj A. Amelioration of diabetes by Swietenia mahagoni in streptozotocin induced diabetic rats. Int J Pharm Sci Res 2015;6:3892.

Panchagula R. Transdermal delivery of zidovudine: Effect of vehicles on permeation across rat skin and their mechanism of action: Pharmacol Res 1997;47:140-56.